Skip to main content
. 2016 May 8;17(3):25–40. doi: 10.1120/jacmp.v17i3.5735

Table 1.

Attributes of patients selected for the development of the virtual phantoms.

Patient No. Disease Site Stage Gender Fractions Delivered Mean Right Parotid Dose (Gy) Mean Left Parotid Dose (Gy) Initial Weight/End of Treatment Weight (kgs) No. of Days Between Planning and EOT Images
1 Base of tongue T2N2bM0 M 35 25.2 25.7 74.8/70.3 60
2 Base of tongue T2N2cM0 F 35 34.7 23.2 68.0/62.1 56
3 Tonsil T2N2bM0 M 35 29.4 25.6 96.2/88.5 57
4 Nasopharynx T1N3M0 F 33 26.7 39.5 65.3/61.2 58
5 Unknown T0N2aM0 M 35 24.5 29.0 90.3/81.2 57
6 Supraglottic larynx T1N1M0 M 33 26.1 21.3 95.3/82.6 43
7 Tonsil T2N2aM0 M 35 14.2 41.7 93.4/86.2 47
8 Tonsil T2N2aM0 F 35 23.5 28.5 106.1/101.6 48
9 Nasopharynx T4N2M0 M 33 55.7 48.7 68.0/56.7 59
10 Base of tongue T0N2aM0 F 35 21.5 23.4 99.8/81.2 68

EOT=end of treatment.